Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Special Issue: Current evidence and perspectives for hypertension management in Asia
  • Published:

Special Issue: Current evidence and perspectives for hypertension management in Asia

Blood pressure management for secondary stroke prevention

Hypertension Research volume 45, pages 936–943 (2022)Cite this article

Abstract

Hypertension is the most important vascular risk factor for stroke; therefore, optimal blood pressure (BP) management is essential for the prevention of recurrent stroke; lowering BP was shown to reduce the risk of recurrent stroke by 25–30%. A recent meta-analysis showed that intensive BP lowering to levels <130/80 mmHg significantly reduced the risk of recurrent stroke compared to standard management with BP levels <140/90 mmHg. The benefit of intensive BP management is evident with regard to a reduced risk of intracranial hemorrhage. Therefore, clinical practice guidelines have established a target BP of <130/80 mmHg. However, the target BP needs to be individualized. A stepped-care approach for cautious BP lowering (usually to levels <140/90 mmHg) is preferred for patients with severe diseases of the major cerebral vessels, who have a high risk of recurrent ischemic stroke. In contrast, more aggressive BP lowering (to levels <120/80 mmHg) tends to benefit patients at high risk of intracranial hemorrhage. The selection of BP management strategies should be guided by the risk of recurrent ischemic and hemorrhagic strokes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–832.

    Article  Google Scholar 

  2. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.

    Article  Google Scholar 

  3. Katsanos AH, Filippatou A, Manios E, Deftereos S, Parissis J, Frogoudaki A, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69:171–9.

    Article  CAS  Google Scholar 

  4. Toyoda K, Nakayama M. Japan Stroke Data Bank. Japan Stroke Data Bank 2021 edited by Editorial Board of Japan Stroke Data bank, Tokyo: National Cerebral and Cardiovascular Center, Nakayama Shoten., Ltd; 2021, p. 20–27.

  5. Chung MK, Eckhardt LL, Chen LY, Ahmed HM, Gopinathannair R, Joglar JA, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association. Circulation. 2020;141:e750–e772.

    Article  Google Scholar 

  6. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249–78.

    Article  Google Scholar 

  7. Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb. 2018;25:846–984.

    Article  Google Scholar 

  8. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.

    Article  Google Scholar 

  9. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl J Med. 2008;359:1225–37.

    Article  CAS  Google Scholar 

  10. Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, Kruyt ND. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018;7:CD007858 https://doi.org/10.1002/14651858.

    Article  CAS  PubMed  Google Scholar 

  11. Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke. 2004;35:116–21.

    Article  CAS  Google Scholar 

  12. SPS3 Study Group, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–15.

    Article  Google Scholar 

  13. Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, et al. Effect of Standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019;76:1309–18.

    Article  Google Scholar 

  14. Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, et al. Intensive or standard blood pressure control in patients with a history of ischemic stroke: respect post-hoc analysis. Hypertens Res. 2022;45:591–601.

  15. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl J Med. 2015;373:2103–16.

    Article  Google Scholar 

  16. Irie K, Yamaguchi T, Minematsu K, Omae T. The J-curve phenomenon in stroke recurrence. Stroke. 1993;24:1844–9.

    Article  CAS  Google Scholar 

  17. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201–8.

    Article  CAS  Google Scholar 

  18. Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011;306:2137–44.

    Article  CAS  Google Scholar 

  19. Hilkens NA, Greving JP, Algra A, Klijn CJ. Blood pressure levels and the risk of intracerebral hemorrhage after ischemic stroke. Neurology. 2017;88:177–81.

    Article  Google Scholar 

  20. Ovbiagele B. Low-normal systolic blood pressure and secondary stroke risk. J Stroke Cerebrovasc Dis. 2013;22:633–8.

    Article  Google Scholar 

  21. Odden MC, McClure LA, Sawaya BP, White CL, Peralta CA, Field TS, et al. Achieved Blood pressure and outcomes in the secondary prevention of small subcortical strokes trial. Hypertension. 2016;67:63–9.

    Article  CAS  Google Scholar 

  22. Biffi A, Anderson CD, Battey TW, Ayres AM, Greenberg SM, Viswanathan A, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA. 2015;314:904–12.

    Article  CAS  Google Scholar 

  23. Estol CJ, Bath PMW, Gorelick PB, Cotton D, Martin RH. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial. Int J Stroke. 2014;9:43–7.

    Article  Google Scholar 

  24. Hoshino T, Sissani L, Labreuche J, Bousser MG, Chamorro A, Fisher M, et al. Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: a post-hoc analysis of the PERFORM study. Eur Stroke J. 2019;4:65–74.

    Article  Google Scholar 

  25. Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke. 2008;39:1740–5.

    Article  Google Scholar 

  26. Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. Lancet Neurol. 2019;18:653–65.

    Article  Google Scholar 

  27. Rothwell PM, Howard SC, Spence JD, Carotid Endarterectomy Trialists’ Collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke. 2003;34:2583–90.

    Article  CAS  Google Scholar 

  28. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969–75.

    Article  Google Scholar 

  29. Yamauchi H, Higashi T, Kagawa S, Kishibe Y, Takahashi M. Impaired perfusion modifies the relationship between blood pressure and stroke risk in major cerebral artery disease. J Neurol Neurosurg Psychiatry. 2013;84:1226–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Tokyo Women’s Medical University, Shinjuku, Tokyo, Japan

    Kazuo Kitagawa

Authors
  1. Kazuo Kitagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuo Kitagawa.

Ethics declarations

Conflict of interest

KK reports grants and personal fees from Daiichi Sankyo, Bayer Inc., grants and personal fees from Nippon Boehringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Astellas Pharma, and Sanofi, and personal fees from Takeda Pharmaceutical outside of the submitted work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitagawa, K. Blood pressure management for secondary stroke prevention. Hypertens Res 45, 936–943 (2022). https://doi.org/10.1038/s41440-022-00908-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-022-00908-1

Keywords

This article is cited by

Search

Advanced search

Quick links